Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,579 | 114,195 | 114,464 | 8,764 | 11,785 |
| TOTAL | $110,241 | $115,630 | $115,101 | $9,761 | $12,873 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 3 |
| Intangibles | 48,648 | 48,648 | 44,466 | 0 | 0 |
| Other Non-Current Assets | 32,793 | 32,907 | 33,018 | 739 | 844 |
| TOTAL | $81,441 | $81,555 | $77,484 | $740 | $847 |
| Total Assets | $191,682 | $197,185 | $192,585 | $10,501 | $13,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,514 | 1,366 | 758 | 150 | 741 |
| Accrued Expenses | 2,595 | 973 | 5,181 | 759 | 953 |
| TOTAL | $4,206 | $2,483 | $6,130 | $1,097 | $1,878 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 48 | 97 |
| TOTAL | $3,605 | $4,106 | $N/A | $48 | $97 |
| Total Liabilities | $7,811 | $6,589 | $6,130 | $1,145 | $1,975 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,307 | 14,307 | 1,431 | 1,078 | 893 |
| Common Shares | 14 | 15 | 1 | 19 | 16 |
| Retained earnings | -88,892 | -80,393 | -74,489 | -68,345 | -65,759 |
| Other shareholders' equity | 0 | 0 | 164,949 | 0 | 0 |
| TOTAL | $183,871 | $190,596 | $186,455 | $9,356 | $11,745 |
| Total Liabilities And Equity | $191,682 | $197,185 | $192,585 | $10,501 | $13,720 |